Who Owns Vivos Therapeutics Stock?
NASDAQ: VVOSHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 3.90%
- Held by insiders
- 11.32%
- Institutional holders
- 24
- Institutions 3.9%
- Insiders 11.3%
- Public and other 84.8%
Who owns Vivos Therapeutics stock?
Institutional investors own about 3.9% of Vivos Therapeutics's shares, spread across 24 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 11.32% of VVOS.
The largest institutional holders are Geode Capital Management, LLC (0.61%), IHT Wealth Management, LLC (0.55%) and Vanguard Capital Management LLC (0.44%). Together, the top 10 institutions control 3.3% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their VVOS positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of VVOS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 85.00K | 0.61% | -11.0% |
| IHT Wealth Management, LLC | 76.74K | 0.55% | +86.9% |
| Vanguard Capital Management LLC | 60.63K | 0.44% | -77.8% |
| Commonwealth Equity Services, LLC | 42.50K | 0.31% | 0.0% |
| UBS Group AG | 39.15K | 0.28% | +254.5% |
| B. Riley Wealth Advisors, Inc. | 38.07K | 0.27% | 0.0% |
| Centurion Wealth Management LLC | 35.68K | 0.26% | 0.0% |
| Blackrock Inc. | 27.82K | 0.20% | 0.0% |
| State Street Corporation | 24.92K | 0.18% | 0.0% |
| Sequoia Financial Advisors, LLC | 24.00K | 0.17% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of VVOS
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 60.77K | 0.44% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 60.63K | 0.44% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 12.07K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 8.35K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Vivos Therapeutics?
Geode Capital Management, LLC is the largest institutional shareholder of VVOS, owning 0.61% of shares outstanding (85.00K shares) as of its latest 13F filing.
What percentage of Vivos Therapeutics is owned by institutions?
Institutions own about 3.9% of VVOS shares and 4.4% of the public float.
How much of Vivos Therapeutics do insiders own?
Insiders, such as officers and directors, own about 11.32% of VVOS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.